发明名称 |
RAPIDLY DISINTEGRATING LYOPHILIZED ORAL FORMULATIONS OF A THROMBIN RECEPTOR ANTAGONIST. |
摘要 |
<p>Disclosed is a lyophilized rapidly disintegrating solid dosage form, one embodiment of which comprises a thrombin receptor antagonist such as, formula (A), or a pharmaceutically acceptable salt or hydrate thereof, a polymer such as gelatin, and a matrix forming agent such as mannitol. Systems for effectively buffering the pre-lyophilized suspension are taught, along with methods of treating patients at risk for acute coronary syndrome by administering such a rapidly disintegrating solid dosage form.</p> |
申请公布号 |
MX2009003360(A) |
申请公布日期 |
2009.04.14 |
申请号 |
MX20090003360 |
申请日期 |
2007.09.24 |
申请人 |
SCHERING CORPORATION. |
发明人 |
VELTRI, ENRICO P.;PAVLOVSKY, ANASTASIA;MONTEITH, DAVID;CHAWDRY, SULIMAN;DUGGIRALA, SRINIVAS;FALVO, MICHAEL ANGELO;ERBEY, JOHN R., II;FENG, KUNG-I |
分类号 |
A61K9/00;A61K9/19;A61K31/4402;A61K31/5377;A61P7/02 |
主分类号 |
A61K9/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|